Arvind Patel M.D.S.C.
Multi-Specialty Clinic in Des Plaines, Illinois — the CMS registry also lists obesity medicine among its taxonomies.
Practice Details
Des Plaines, IL 60016
Specialty taxonomies on file (2)
- Bariatric SurgerySurgery
- PrimaryMulti-Specialty ClinicClinic/Center, Multi-Specialty
All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.
About This Practice
Arvind Patel M.D.S.C. is enumerated with NPPES as a Multi-Specialty Clinic; the CMS registry also lists obesity medicine among its taxonomies. The registry does not break out which specialties are staffed at this location — call ahead to confirm obesity-medicine or GLP-1 services are actively offered here.
This practice address has 1 individual clinician enumerated with NPPES under the same location.
Locally, this is 1 of 14 Multi-Specialty Clinic/Center practices in Des Plaines carrying this exact taxonomy in our directory.
What to expect at a Multi-Specialty Clinic visit
A multi-specialty clinic houses more than one type of clinician under one roof, so the exact pathway depends on which department you see. In general, expect:
- •An intake that routes you to the appropriate clinician (primary care, endocrinology, or obesity medicine).
- •Screening labs where indicated before any medication is started.
- •A discussion of whether GLP-1 therapy is managed in-house or via referral.
- •Confirmation of which services and clinicians are staffed at this location — call ahead, since the registry does not break this out.
This is general guidance for multi-specialty clinic practices, not a description of Arvind Patel M.D.S.C.'s specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 847-813-0700.
GLP-1 access in Des Plaines, Illinois
About 32.4% of Illinois adults have obesity (BMI 30+), ranking the state #26 of 50 (CDC BRFSS). Our directory currently lists 8 GLP-1-relevant clinics in Des Plaines. If a cash-pay route makes more sense, compounded semaglutide through Illinois telehealth averages about $209/mo — well below brand-name Wegovy or Zepbound.
Explore more Illinois options on the best Illinois GLP-1 providers page, browse every Des Plaines listing in the Des Plaines clinic directory, or read the Illinois Medicaid GLP-1 coverage & prior-authorization guide.
Related Practices in Des Plaines
Other Des Plaines listings in the same directory tier:
Telehealth Alternative
Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Illinois addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Illinois telehealth partners:
Featured Partners · Des Plaines
Featured GLP-1 providers serving Des Plaines
No insurance needed
reader-supported
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
- Top pick7.6Get started →Save $1,099.01/mo vs Wegovy
Compounded from
$249.99/mo
- 8.3Get started →Save $1,250/mo vs Wegovy
Compounded from
$99/mo
- 7.4Get started →Save $1,150/mo vs Wegovy
Compounded from
$199/mo
- 6.2Get started →Save $1,202/mo vs Wegovy
Compounded from
$147/mo
- 8.2Get started →Save $937/mo vs Zepbound
Compounded from
$149/mo
- 6.9Get started →Save $1,100/mo vs Wegovy
Compounded from
$249/mo
| Provider | Compounded from | Save vs brand | |
|---|---|---|---|
7.6MaximusTop pick | $249.99/mo | Save $1,099.01/mo | Get started → |
8.3Found | $99/mo | Save $1,250/mo | Get started → |
7.4Breeze Meds | $199/mo | Save $1,150/mo | Get started → |
6.2Wellorithm | $147/mo | Save $1,202/mo | Get started → |
8.2Gala | $149/mo | Save $937/mo | Get started → |
6.9TMates | $249/mo | Save $1,100/mo | Get started → |
See more Des Plaines options on the Des Plaines clinic directory, or compare the best semaglutide providers nationwide.
Learn more about the medications most commonly prescribed by Des Plaines obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.